CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ DEFICIT - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-in Capital	Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023		4,073,000
Beginning balance at Dec. 31, 2023	$ (27,992)	$ 0	$ 94,544	$ (122,536)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,458)			(7,458)
Stock options exercised (in shares)		4,000
Stock options exercised	18		18
Vesting of restricted stock units (in shares)		122,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(30,000)
Repurchases of restricted stock for payroll tax withholding	(457)		(457)
Stock-based compensation expense	2,943		2,943
Ending balance (in shares) at Jun. 30, 2024		4,169,000
Ending balance at Jun. 30, 2024	(32,946)	$ 0	97,048	(129,994)
Beginning balance (in shares) at Mar. 31, 2024		4,106,000
Beginning balance at Mar. 31, 2024	(27,483)	$ 0	95,623	(123,106)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(6,888)			(6,888)
Stock options exercised (in shares)		4,000
Stock options exercised	18		18
Vesting of restricted stock units (in shares)		67,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(8,000)
Repurchases of restricted stock for payroll tax withholding	(145)		(145)
Stock-based compensation expense	1,552		1,552
Ending balance (in shares) at Jun. 30, 2024		4,169,000
Ending balance at Jun. 30, 2024	$ (32,946)	$ 0	97,048	(129,994)
Beginning balance (in shares) at Dec. 31, 2024	4,446,540	4,447,000
Beginning balance at Dec. 31, 2024	$ (46,794)	$ 0	101,657	(148,451)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(13,523)			(13,523)
Issuance of warrants in connection with the Refinancing Agreement	3,934		3,934
Vesting of restricted stock units (in shares)		75,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(36,000)
Repurchases of restricted stock for payroll tax withholding	(361)		(361)
Stock-based compensation expense	1,930		1,930
Issuance of shares due to litigation settlement (in shares)		84,000
Issuance of shares due to litigation settlement	$ 752		752
Ending balance (in shares) at Jun. 30, 2025	4,569,546	4,570,000
Ending balance at Jun. 30, 2025	$ (54,062)	$ 0	107,912	(161,974)
Beginning balance (in shares) at Mar. 31, 2025		4,484,000
Beginning balance at Mar. 31, 2025	(51,687)	$ 0	102,452	(154,139)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss	(7,835)			(7,835)
Issuance of warrants in connection with the Refinancing Agreement	3,934		3,934
Vesting of restricted stock units (in shares)		13,000
Repurchase of restricted stock for payroll tax withholding (in shares)		(11,000)
Repurchases of restricted stock for payroll tax withholding	(90)		(90)
Stock-based compensation expense	864		864
Issuance of shares due to litigation settlement (in shares)		84,000
Issuance of shares due to litigation settlement	$ 752		752
Ending balance (in shares) at Jun. 30, 2025	4,569,546	4,570,000
Ending balance at Jun. 30, 2025	$ (54,062)	$ 0	$ 107,912	$ (161,974)